FLT3LG and glioblastoma: established a rat intracranial glioblastoma model in which Flt3L and herpes simplex virus type 1–thymidine kinase, delivered intratumorally by replication-defective recombinant adenovirus type 5 vectors, was able to control tumors in combination with the antiviral drug Ganciclovir.